52 VANDERBILT AVENUE, NEW YORK, NY, UNITED STATES, 10017
國家
美國
上市日期
2026-04-15
財年截止
十二月
流通股數
27.47M
CIK
--
官方網址
--
NewHold Investment Corp IV (NHIV) 是一家特殊目的收購公司(SPAC),專注於識別並主要與科技及醫療保健行業的高增長企業合併。憑藉其資本及行業專業知識,NHIV 旨在促進具顯著增長潛力的創新公司之發展。該公司致力透過策略夥伴合作創造價值,同時定位自身以把握新興市場趨勢。NewHold Investment Corp IV 由一支在營運管理及投資方面擁有豐富經驗的專業團隊領導,具備推動成功合併並為投資者帶來可觀回報的能力。
財務指標
營業收入
2026-06-30
$0
2026-03-31
$0
2025-12-31
$0
營業支出
2026-06-30
$619K
2026-03-31
$38K
2025-12-31
$47K
淨利潤
2026-06-30
$854K
2026-03-31
-$38K
2025-12-31
-$47K
淨利潤率
2026-06-30
--
2026-03-31
--
2025-12-31
--
每股收益
2026-06-30
$0.03
2026-03-31
--
2025-12-31
--
息稅折舊攤銷前利潤
2026-06-30
-$619K
2026-03-31
-$38K
2025-12-31
-$47K
有效稅率
2026-06-30
--
2026-03-31
--
2025-12-31
--
項目
2026-06-30
2026-03-31
2025-12-31
營業收入
$0
$0
$0
營業支出
$619K
$38K
$47K
淨利潤
$854K
-$38K
-$47K
淨利潤率
--
--
--
每股收益
$0.03
--
--
息稅折舊攤銷前利潤
-$619K
-$38K
-$47K
有效稅率
--
--
--
常見問題
NHIV is a U.S.-listed stock ticker representing shares of a publicly traded company. The specific business operations, sector, and listing exchange for NHIV are detailed on the stock's profile page, which displays the latest company description. Investors can review that page to confirm the company's legal name, headquarters, and primary activities before researching further.
Recent performance for NHIV is shown through current and historical price data on the stock detail page, including daily changes and longer-term trends. Because prices move continuously during market hours, the most accurate recent performance figures are those displayed there. Reviewing that data alongside volume and broader market conditions can help put NHIV's recent moves into context.
Evaluating NHIV's valuation typically involves comparing its market price against fundamental metrics such as earnings, book value, and revenue, using ratios like P/E or price-to-sales. These figures for NHIV are available on the stock detail page and in its financial statements. Comparing those metrics with peer companies and the broader market can help investors assess whether NHIV appears relatively expensive or inexpensive.
NHIV may trade in pre-market and after-hours sessions through certain brokers, though liquidity outside regular U.S. market hours is often thinner and spreads can be wider. Not all brokers support extended-hours trading for every stock, so availability for NHIV depends on the platform. The stock detail page shows the latest price data, which may reflect extended-hours activity where applicable.
Analyzing NHIV's financial performance generally starts with its quarterly and annual reports, including the income statement, balance sheet, and cash flow statement. Key items to review include revenue growth, margins, net income, and cash generation. The stock detail page and SEC filings provide these figures for NHIV, allowing investors to compare results across periods and against industry peers.
Risks for NHIV depend on its specific business, but common factors include industry competition, revenue concentration, debt levels, and sensitivity to economic cycles. Market-wide risks such as interest rate changes and investor sentiment can also affect the share price. NHIV's SEC filings, particularly the risk factors section, outline company-specific risks that investors should review before making any decisions.